Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients – the Vienna Cohort

Overview of attention for article published in Frontiers in immunology, December 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 60 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 33,790 followers.

Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort https://t.co/VCXiSky9Cm

20 Dec 2021

Reply Repost Favourite

RT @FrontImmunol: New Research: Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients – the V…

03 Dec 2021

Reply Repost Favourite

RT @FrontImmunol: New Research: Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients – the V…

02 Dec 2021

Reply Repost Favourite

New Research: Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients – the Vienna Cohort: Background Dialysis patients are at high risk for a severe clinical course after infection with severe… https://t.co/njjd

02 Dec 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.